Search results
ASAM developed the National Practice Guideline to provide information on evidence-based treatment of opioid use disorder and is the first to address all of the FDA-approved medications available to treat addiction involving opioid use and opioid overdose in a single document.
Dec 7, 2023 · The National Practice Guideline (NPG) from the American Society of Addiction Medicine (ASAM) is intended to inform and empower clinicians, health system administrators, criminal justice system administrators, and policymakers who are interested in implementing evidence-based practices to improve outcomes for individuals with opioid use disorder.
Opioid Addiction Treatment: A Pocket Guide for Patients, Families, and Friends. This patient guide includes information on assessment, treatment overview (including treatment plans, patient participation, and counseling), and all the medications available to treat opioid use and overdose.
Aug 9, 2021 · The NPG is the first set of guidelines to address all currently FDA-approved medications available to treat OUD and opioid withdrawal, including all available buprenorphine formulations, in a single document.
- www.ncbi.nlm.nih.gov
- › …
- › CMAJ
- › v.190(9); 2018 Mar 5
Mar 3, 2018 · This guideline is intended to serve as a tool to address current gaps in care for opioid use disorder, addiction-medicine training for clinicians and other health care professionals, and treatment access policies across the country.
- nida.nih.gov
- › NIDAMED: Clinical Resources
Mar 17, 2023 · In 2021, only 22% of people aged 12 or older with an opioid use disorder received medication treatment in the past year (2021 DT 5.43B). * 1 The links below provide evidence-based information on practice guidance, emergency department treatment, and overdose treatment.
Jul 25, 2022 · Treatment Options. Patients should have all FDA-approved medications available to them for treatment of opioid use disorder. Treatment options should be discussed and decided by the patient and the practitioner. Practitioners should consider past treatment history and setting, as well as the patient's preferences.
The 2020 update of clinical practice guidelines for treating opioid use disorder (OUD) from the American Society of Addiction Medicine is intended for clinicians who assess patients for OUD and prescribe medications, other health care providers, medical educators, and clinical care managers.
Jan 17, 2024 · The Mainstreaming Addiction Treatment (MAT) Act provision updates federal guidelines to expand the availability of evidence-based treatment to address the opioid epidemic. The MAT Act empowers all health care providers with a controlled substance certificate to prescribe buprenorphine for OUD, just as they prescribe other essential medications.
Nov 4, 2022 · The guideline addresses the following four areas: 1) determining whether or not to initiate opioids for pain, 2) selecting opioids and determining opioid dosages, 3) deciding duration of initial opioid prescription and conducting follow-up, and 4) assessing risk and addressing potential harms of opioid use.
